Victor E. Reuter

111.4k total citations · 13 hit papers
509 papers, 41.7k citations indexed

About

Victor E. Reuter is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Victor E. Reuter has authored 509 papers receiving a total of 41.7k indexed citations (citations by other indexed papers that have themselves been cited), including 315 papers in Pulmonary and Respiratory Medicine, 201 papers in Surgery and 171 papers in Molecular Biology. Recurrent topics in Victor E. Reuter's work include Renal cell carcinoma treatment (129 papers), Prostate Cancer Treatment and Research (119 papers) and Renal and related cancers (109 papers). Victor E. Reuter is often cited by papers focused on Renal cell carcinoma treatment (129 papers), Prostate Cancer Treatment and Research (119 papers) and Renal and related cancers (109 papers). Victor E. Reuter collaborates with scholars based in United States, Canada and Spain. Victor E. Reuter's co-authors include Paul Russo, Holger Moch, Peter A. Humphrey, Antonio L. Cubilla, Thomas M. Ulbright, Robert J. Motzer, Satish K. Tickoo, Guido Dalbagni, Peter T. Scardino and Samson W. Fine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Victor E. Reuter

503 papers receiving 40.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

2016 2.1k citations Victor E. Reuter et al. profile →
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images

2019 1.4k citations Matthew G. Hanna, Victor E. Reuter et al. profile →
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours

2016 1.3k citations Victor E. Reuter et al. profile →
The Heidelberg classification of renal cell tumours

1997 1.0k citations Brett Delahunt, John N. Eble et al. profile →
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

2015 945 citations Jonathan I. Epstein, Michael J. Zeléfsky et al. profile →
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

1999 703 citations Victor E. Reuter et al. PubMed profile →
Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

2004 609 citations Robert J. Motzer, Victor E. Reuter et al. profile →
A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA

2001 557 citations Victor E. Reuter, Robert J. Motzer et al. profile →
HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

2001 553 citations Michael J. Zeléfsky, Victor E. Reuter et al. profile →
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

2016 531 citations A. Ari Hakimi, Chung‐Han Lee et al. profile →
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

2014 375 citations Jonathan I. Epstein, Mahul B. Amin et al. The American Journal of Surgical Pathology profile →
Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores

2015 321 citations Debra A. Goldman, Samson W. Fine et al. profile →
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

2015 259 citations Debra A. Goldman, Behfar Ehdaie et al. profile →

Peers

Victor E. Reuter

PRM

SURGE

ONCOL

Rodolfo Montironi Italy

Mahul B. Amin United States

Theodorus van der Kwast Netherlands

Jonathan I. Epstein United States

Alan W. Partin United States

Peter T. Scardino United States

Peter A. Humphrey United States

Maria J. Merino United States

Holger Moch Switzerland

Thomas M. Wheeler United States

Rodolfo Montironi Italy

Victor E. Reuter

16.3k ×0.7

PRM

9.7k ×0.6

10.3k ×0.8

SURGE

5.0k ×0.6

5.9k ×0.8

ONCOL

Citations per year, relative to Victor E. Reuter Victor E. Reuter (= 1×) peers Rodolfo Montironi

Countries citing papers authored by Victor E. Reuter

Since Specialization

Citations

This map shows the geographic impact of Victor E. Reuter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor E. Reuter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor E. Reuter more than expected).

Fields of papers citing papers by Victor E. Reuter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor E. Reuter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor E. Reuter. The network helps show where Victor E. Reuter may publish in the future.

Co-authorship network of co-authors of Victor E. Reuter

This figure shows the co-authorship network connecting the top 25 collaborators of Victor E. Reuter. A scholar is included among the top collaborators of Victor E. Reuter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor E. Reuter. Victor E. Reuter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reuter, Victor E., et al.. (2024). Primary Well-Differentiated Neuroendocrine Tumor/Carcinoid of the Prostate: Case Report and Review of Literature. International Journal of Surgical Pathology. 32(7). 1374–1378. 2 indexed citations

Ardon, Orly, Maria A. Friedlander, Lorraine Corsale, et al.. (2023). Quality Management System in Clinical Digital Pathology Operations at a Tertiary Cancer Center. Laboratory Investigation. 103(11). 100246–100246. 10 indexed citations

Zeléfsky, Michael J., Debra A. Goldman, Sean M. McBride, et al.. (2021). Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. Radiotherapy and Oncology. 159. 33–38. 20 indexed citations

Teo, Min Yuen, Hikmat Al‐Ahmadie, Kenneth Seier, et al.. (2021). Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma. British Journal of Cancer. 124(7). 1214–1221. 21 indexed citations

Al‐Obaidy, Khaleel I., Julia A. Bridge, Liang Cheng, et al.. (2021). EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Modern Pathology. 34(10). 1921–1934. 34 indexed citations

Feldman, Darren R., Yasser Ged, Chung‐Han Lee, et al.. (2020). Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. Cancer. 126(24). 5247–5255. 27 indexed citations

Hakimi, A. Ari, Martin H. Voss, Fengshen Kuo, et al.. (2019). Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial. Cancer Discovery. 9(4). 510–525. 156 indexed citations

Shanks, Jonathan H., John R. Srigley, Fadi Brimo, et al.. (2019). Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 75(4). 453–467. 2 indexed citations

Voss, Martin H., A. Ari Hakimi, Can G. Pham, et al.. (2014). Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy. Clinical Cancer Research. 20(7). 1955–1964. 156 indexed citations

10.

Hakimi, A. Ari, Irina Ostrovnaya, Boris Reva, et al.. (2013). Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network. Clinical Cancer Research. 19(12). 3259–3267. 267 indexed citations

11.

López-Lago, Miguel A., Venkata J. Thodima, Asha Guttapalli, et al.. (2010). Genomic Deregulation during Metastasis of Renal Cell Carcinoma Implements a Myofibroblast-Like Program of Gene Expression. Cancer Research. 70(23). 9682–9692. 27 indexed citations

12.

Ouyang, Xuesong, Walter J. Jessen, Hikmat Al‐Ahmadie, et al.. (2008). Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. Cancer Research. 68(7). 2132–2144. 108 indexed citations

13.

Huang, Qin, Raj K. Goyal, Adebowale Adeniran, et al.. (2007). Genitourinary. Modern Pathology. 20. 133–186. 1 indexed citations

14.

Korkola, James E., Jane Houldsworth, Rajendrakumar S.V. Chadalavada, et al.. (2006). Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors. Cancer Research. 66(2). 820–827. 236 indexed citations

15.

Sharma, Padmanee, Yu Shen, Sijin Wen, et al.. (2006). Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma. Clinical Cancer Research. 12(18). 5442–5447. 75 indexed citations

16.

Al‐Abbadi, Mousa A., Walid Abuhammour, Husain A. Saleh, et al.. (2005). Pediatrics. Modern Pathology. 18. 303–307. 1 indexed citations

17.

Argani, Pedram, Cristina R. Antonescu, Jérôme Couturier, et al.. (2002). PRCC-TFE3 Renal Carcinomas. The American Journal of Surgical Pathology. 26(12). 1553–1566. 259 indexed citations

18.

Tickoo, Satish K., Victor E. Reuter, Mahul B. Amin, et al.. (1999). Renal Oncocytosis. The American Journal of Surgical Pathology. 23(9). 1094–1094. 150 indexed citations

19.

Amin, Mahul B., William M. Murphy, Victor E. Reuter, et al.. (1996). A symposium on controversies in the pathology of transitional cell carcinomas of the urinary bladder, Part II.. PubMed. 1. 1–110. 11 indexed citations

20.

Sarkis, A. S., Elizabeth Charytonowicz, Carlos Cordon‐Cardo, et al.. (1994). Blood group antigen expression in bladder tumors: An immunohistochemical study of superficial bladder lesions. Journal of Experimental & Clinical Cancer Research. 13(2). 139–144. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact